Cite

HARVARD Citation

    Sands, B. et al. (2021). Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib—Implications for Cardiovascular Risk and Patient Management. Inflammatory bowel diseases. 27 (6), pp. 797-808. [Online]. 
  
Back to record